Form 8-K SEATTLE GENETICS INC For: Oct 25

Go back to Form 8-K SEATTLE GENETICS INC For: Oct 25

Seattle Genetics (SGEN) PT Lowered to $92 at RBC Capital

October 26, 2018 7:35 AM EDT

RBC Capital analyst Kennen MacKay lowered the price target on Seattle Genetics (NASDAQ: SGEN) to $92.00 (from $98.00) while maintaining a Outperform rating.

The analyst notes the surprise Adcetris miss brings questions to 1L HL aspect of bull thesis.

... More